thiazoles has been researched along with yc137 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Fernandez-Luna, JL; Nikolovska-Coleska, Z; Real, PJ; Sanz-Ortiz, J; Wang, R; Wang, S | 1 |
| Atayar, C; Bosga-Bouwer, A; Kluin, P; Rosati, S; Visser, L; Wang, M | 1 |
| Choo, HL; Khoo, AS; Leong, CO; Low, SY; Tan, BS; Tiong, KH | 1 |
| Negoro, E; Nishi, R; Takemura, H; Ueda, T; Yamauchi, T | 1 |
| Cairó, JJ; Gòdia, F; Milián, E; Prats, E; Vives, J | 1 |
| Dalal, H; Damodar, S; Gowda, DA; H, K; Subramanian, S; V P, S; Vyas, N | 1 |
6 other study(ies) available for thiazoles and yc137
| Article | Year |
|---|---|
Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Humans; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; STAT3 Transcription Factor; Thiazoles; Trans-Activators | 2004 |
JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125.
Topics: Anthracenes; Apoptosis; Case-Control Studies; Cell Cycle; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Lymphoma, Mantle-Cell; Palatine Tonsil; Polyploidy; Proto-Oncogene Proteins c-bcl-2; Thiazoles | 2009 |
Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Humans; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-bcl-2; Thiazoles | 2012 |
Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arabinonucleosides; Cytarabine; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Proto-Oncogene Proteins c-bcl-2; Thiazoles | 2013 |
BHRF1 exerts an antiapoptotic effect and cell cycle arrest via Bcl-2 in murine hybridomas.
Topics: Animals; Apoptosis; Batch Cell Culture Techniques; Benzopyrans; Cell Cycle Checkpoints; Cell Line; Hybridomas; Membrane Potential, Mitochondrial; Mice; Mitochondria; Nitriles; Proto-Oncogene Proteins c-bcl-2; Thiazoles; Transfection; Up-Regulation; Viral Proteins | 2015 |
Exovesicular-Shh confers Imatinib resistance by upregulating Bcl2 expression in chronic myeloid leukemia with variant chromosomes.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Thiazoles; Up-Regulation; Veratrum Alkaloids | 2021 |